2024
Neuroimaging Biomarkers in Parkinson’s Disease
Holmes S, Tinaz S. Neuroimaging Biomarkers in Parkinson’s Disease. Advances In Neurobiology 2024, 40: 617-663. PMID: 39562459, DOI: 10.1007/978-3-031-69491-2_21.Peer-Reviewed Original ResearchConceptsPublic health burdenNeuroimaging biomarkersTreatment developmentRisk of developing PDParkinson's diseaseHealth burdenDiagnosis of PDMultimodal neuroimaging techniquesIdiopathic Parkinson's diseaseNon-motorDifferential diagnosis of PDNeuroimaging techniquesProdromal phaseDifferential diagnosisSymptomatic treatmentDisease progressionClinical applicationBiomarkers
2022
Characterization of Early Stage Parkinson's Disease From Resting-State fMRI Data Using a Long Short-Term Memory Network
Guo X, Tinaz S, Dvornek N. Characterization of Early Stage Parkinson's Disease From Resting-State fMRI Data Using a Long Short-Term Memory Network. Frontiers In Neuroimaging 2022, 1: 952084. PMID: 37555151, PMCID: PMC10406199, DOI: 10.3389/fnimg.2022.952084.Peer-Reviewed Original ResearchEarly-stage Parkinson's diseaseFunctional magnetic resonance imagingParkinson's Progression Markers InitiativeParkinson's diseaseProgression Markers InitiativeDiagnosis of PDEarly-stage diseaseFunctional brain changesBrain function alterationsStage Parkinson's diseaseFunctional connectivity differencesComplex neurodegenerative disorderMagnetic resonance imagingResting-state fMRI dataStage diseaseDisease stageDisease progressionBrain changesTreatment responseMotor impairmentFC changesNew therapiesFunction alterationsResonance imagingBrain regions